Sallie Bernard* Albert Enayati, B. S., Ch. E., M. S. M. E. Heidi Roger




НазваниеSallie Bernard* Albert Enayati, B. S., Ch. E., M. S. M. E. Heidi Roger
страница16/17
Дата конвертации27.10.2012
Размер0.74 Mb.
ТипДокументы
1   ...   9   10   11   12   13   14   15   16   17

Clarkson, T. 1997 ‘The Toxicology of Mercury’, Critical Reviews in Clinical Laboratory Sciences, 34(3): 369-403 (1997)

Clarkson, TW, ‘Mercury - an element of mystery’, The New England Journal of Medicine 1990 Oct 18

Clarkson,T.W, 1993, 'Molecular and ionic mimicry of toxic metals', Annu. Rev. Pharmacol. Toxicol. 32:545-571

Cloarec S, Deschenes G, Sagnier M, Rolland JC, Nivet H, ‘Arterial hypertension due to mercury poisoning: diagnostic value of captopril’, Arch Pediatr 1995 Jan;2(1):43-46

Close AH, Guo TL, Shenker BJ, ‘Activated human T lymphocytes exhibit reduced susceptibility to methylmercury chloride-induced apoptosis’, Toxicol Sci 1999 May;49(1):68-77

Coccini T, Randine G, Candura SM, Nappi RE, Prockop LD, Manzo L, ‘Low-Level Exposure to Methylmercury Modifies Muscarinic Cholinergic Receptor Binding Characteristics in Rat Brain and Lymphocytes: Physiologic Implications and New Opportunities in Biologic Monitoring’, Environ Health Perspect, 2000 Jan;108(1):29-33

Coleman M, ‘Nutritional treatments currently under investigation in autism’, Clinical Nutrition, Sept/Oct 1989, Vol. 8, No. 5, pp. 210-212

Comi AM, Zimmerman A et al, 'Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism', Journal of Child Neurology, 1999, Vol. 14, pp. 388-394

Connolly AM, et al, ‘Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders’, Journal of Pediatrics, May 1999, Vol. 134, No. 5, pp. 607-613

Cook EH, ‘Autism: review of neurochemical investigation’, Synapse, 1990, 6:292-308

Courchesne E, et al, ‘More evidence links autism, cerebellar defects’, reviewed in Autism Research Review International, 1994, Vol. 8, No. 2, pp. 1&7

Courchesna E, Press GA, Young-Courchesne R, 'Parietal lobe abnormalities detected with MR in patients with infantile autism', AJR Am J Roentgenol 1993 Feb;160(2):387-93

Courchesne E, 'Brainstem, cerebellar and limbic neuroanatomical abnormalities in autism', Current Opin Neurobiol 1997 Apr;7(2):269-78

Courchesne E, Saitoh O, Townsend J, Yeung-Courchesne R, Lincoln AJ, Schreibman L, Haas RH, Press GA, 'Cerebellar Abnormalities in Autism: New Evidence and A Re-Analysis of Old Evidence', pp. 211-214

Courchesne E, Yeung-Courchesne R, Elmasian R, Grillon C, 'Pathophysiologic findings in non-retarded autism and receptive developmental language disorder', Journal of Autism and Developmental Disorders, 1989; 19:1-17

Courchesne E, Yeung-Courchesne R, Press GA, Hesselink JR, Jernigan TL, ‘Hypoplasia of cerebellar vermal lobules VI and VII in autism’, New England Journal of Medicine 1988 318:1349-1354

Courchesne E, Yeung-Courchesne R, Press GA, Hesselink JR, Jernigan TL, ‘Hypoplasia of cerebellar vermal lobules VI and VII in autism’, New England Journal of Medicine, May 26, 1998; pp. 1349-1354

Courchesne E, reported in The New York Times, 'Science Times' section, Dec 28, 1999, by Blakeslee S

Cox NH, Forsyth A, ‘Thiomersal allergy and vaccination reactions’, Contact Dermatitis 1988:18:229-233

Creel DJ, Crandall AS, Pingree C, Ritvo ER, 'Abnormal electroretinograms in autism', Clinical Vision Science 1989 4(1):85-88

Cuomo V, Ambrosi L, Annau Z, Cagiano R, Brunello N, Racagni G 1984, ‘Behavioral and neurochemical changes in offspring of rats exposed to methyl mercury during gestation’, Neurobehavior Toxicology Teratol 1984 May-June;6(3):249-254

D’Eufemia P, Celli M, Finocchiaro R, Pacifico L, Viozzi L, Zaccagnini M, Cardi E, Giardini O, ‘Abnormal intestinal permeability in children with autism’, Acta Pædiatr 1996:85:1076-1079

D’Eufemia P, Finocchiaro R, Celli M, Viozzi L, Monteleone D, Giardini O, ‘Low serum tryptophan to large neutral amino acids ratio in idiopathic infantile autism’, Biomed. & Pharmacother., 1995, Vol. 49, pp. 288-292

Dales LD, ‘The Neurotoxicity of Alkyl Mercury Compounds’, American journal of Medicine, August 1972, Vol. 53, 219-232

Dally A, 'The Rise and Fall of Pink Disease', Wellcome Institute for the History of Medicine, 1997, available at www.users.bigpond.com/difarnsworth

Dathan JG, 'Pink Disease-Ten Years After (The Epilogue), British Medical Journal, 1965, Vol 1, pp. 1181-1182

Dave V, Mullaney KJ, Goderie S, Kimelberg HK, Aschner M, ‘Astrocytes as mediators of methylmercury neurotoxicity: effects on D-aspartate and serotonin uptake’, Dev Neurosci 1994;16(3-4):222-231

Davis LE, Kornfeld M, Mooney HS, Fiedler KJ, Haaland KY, Orrison WW, Cernichiari E, Clarkson TW, ‘Methylmercury poisoning: long term clinical, radiological, toxicological, and pathological studies of an affected family’, Annals of Neurology 1994 35:6 680-688

Dawson G, ‘Brief Report: Neuropsychology of Autism: A Report on the State of the Science’, Journal of Autism and Developmental Disorders, 1996, Vol. 26, No. 2, 179-184

Deb S and Thompson B, ‘Neuroimaging in autism’, British Journal of Psychiatry 1998 Oct 173:299-302

DelGiuidce-Asch G, Hollander E, ‘Altered immune function in autism’, CNS Spectrums: International Journal of Neuropsychiatric Medicine, 1997, 2:61-68

DeLong GR, ‘Autism: new data suggest a new hypothesis’, Neurology, March 1999, Vol. 52, No. 5, pp. 911-916

Deutsch S, Campbell M, Sachar E, Green W, David R, ‘Plasma growth hormone response to oral L-dopa in infantile autism’, Journal of Autism and Developmental Disorders, June 1985, Vol. 15, No. 2, pp. 205-212

Deyab P, Gochfeldbc M, Reuhlabca K, 'Developmental Methylmercury Administration Alters Cerebellar PSA-NCAM expression and Golgi sialyltransferase Activity', 1999

Diner Barry, M.D., Brenner Barry, M.D.,Toxicity, Mercury, 1998

Edelson MG, Edelson SM, Jung S, ‘Assessing the Intelligence of Individuals with Autism: A Cross-Cultural Replication of the Usefulness of the TONI’, Focus on Autism and Other Developmental Disabilities, Winter 1998, Vol. 13, No. 4, 221-227

Edelson MG, Schubert DT, Edelson SM, ‘Factors Predicting Intelligence Scores on the TONI in Individuals with Autism’, Focus on Autism and Other Developmental Disabilities, Spring 1998, Vol. 13, No. 1, 17-26

Edelson SB, Cantor DS, ‘Autism: xenobiotic influences’, Toxicol Ind Health, 1998 Jul-Aug;14(4):553-563

Egan, William M. 1999 ‘Thimerosal in Vaccines’, presentation to the FDA, September 14, 1999

Eisenmayer R et al, 'Delayed language onset as a predictor of clinical symptoms in pervasive developmental disorders', Journal of Autism and Developmental Disorders, 1998 Dec 28(6):527-33

El-Fawal HA, Waterman SJ, De Feo A, Shamy MY, ‘Neuroimmunotoxicology: Humoral Assessment of Neurotoxicity and Autoimmune Mechanisms’, Environ Health Perspect 1999 Oct;107(Suppl 5):767-775

El-Fawal HA, Waterman SJ, DeFeo A, Shamy MY, ‘Neuroimmunotoxicology: Humoral Assessment of Neurotoxicity and Autoimmune Mechanisms’, Environ Health Perspect 1999 Oct;107(Suppl5):767-775

Elferink JG Thimerosal: a versatile sulfhydryl reagent,calcium mobilizer, and cell function-modulating agent.Gen Pharmacol 1999 Jul;33(1):1-6

Environmental Protection Agency (EPA), lead authors - Hassett-Sipple B, Swartout J, Schoeny R, 'Vol. V - Health Effects of Mercury and Mercury Compounds', Mercury Study Report to Congress, December 1997

Ernst M, Zametkin AJ, Matochik JA, Pascualvaca D, Cohen RM, 'Low medial prefrontal dopaminergic activity in autistic children', Lancet 1997 Aug 30;350(9078):638

Eto K, Takizawa Y, Akagi H, Haraguchi K, Asano S, Takahata N, Tokunaga H, ‘Differential diagnosis between organic and inorganic mercury poisoning in human cases - the pathologic point of view’, Toxicol Pathol 1999 Nov-Dec;27(6):664-671

Fagala GE,Wigg CL, ‘Psychiatric Manifestions of Mercury Poisoning’, J. Am. Acad. Child. Adolesc. Psychiatry, March 1992, 31(2):306-311.

Fagan DG, Pritchard JS, Clarkson TW, Greenwood MR, ‘Organ mercury levels in infants with omphaloceles treated with organic mercurial antiseptic’, Archives of Disease in Childhood, 1977 52:962-964

Farnsworth D, ‘Pink Disease Survey Results’, Pink Disease Support Group Site, 1997 www.users.bigpond.com/difarnsworth

Faro LR, Duran R, do Nascimento JL, Alfonso M, Picanco-Diniz CW, ‘Effects of methyl mercury on the in vivo release of dopamine and its acidic metabolites DOPAC and HVA from Striatum of rats’, Ecotoxicol Environ Saf 1997 Nov;38(2):95-98

Faro LRF, Nascimento JLM do, Alfonso M, Duran R, ‘Acute Administration of Methylmercury Changes In Vivo Dopamine Release from Rat Striatum’, Bulletin of Environmental Contamination Toxicology, 1998 60:632-638

FDA, HHS, ‘Mercury Containing Drug Products for Topical Antimicrobial Over-the-Counter Human Use; Establishment of a Monograph’, Federal Register, January 5 1982, Vol. 47, No. 2, 436-442

FDA, 'Mercury Compounds in Drugs and Food', 98N-1109, November 16, 1999

Feldman R, 'Neurological Manifestations of Mercury Intoxication', Journal of Occupational Neurology, 1982, Vol. 66, pp. 201-209

Filipek P, Accardo P, Baranek G, Cook E, Dawson G, Gordon B, Gravel J, Johnson C, Kallen R, Levy S, Minshew N, Prizant B, Rapin I, Rogers S, Stone W, Teplin S, Tuchman R, Volkmar F, 'The Screening and Diagnosis of Autistic Spectrum Disorders', Journal of Autism and Developmental Disorders, 1999, Vol. 29, No. 6, pp. 439-484

Filipek PA, Accardo PJ, Baranek GT, Cook Jr. EH, Dawson G, Gordon B, Gravel JS, Johnson CP, Kallen RJ, Levy SE, Minshew NJ, Prizant BM, Rapin I, Rogers SJ, Stone WL, Teplin S, Tuchman RF, Volkmar FR, ‘The Screening and Diagnosis ot Autistic Spectrum Disorders’, Journal of Autism and Developmental Disorders, 1999, Vol. 29, No. 6, 439-484

Finegan J, Quarrington B, 'Pre-, peri-, and neonatal factors and infantile autism', J Child Psychol Psychi, 1979; 20.119-128

Florentine MJ and Sanfilippo II DJ, ‘Grand Rounds: Elemental mercury poisoning’, Clinical Pharmacy 1991 Mar 10:213-221

Fombonne E, Rogé B, Claverie J, Courty S, Frémolle J, ‘Microcephaly and Macrocephaly in Autism’ Journal of Autism and Developmental Disorders, 1999, Vol. 29, No. 2, 113-119

Food and Drug Administration, 1997 ‘Status of Certain Additional Over-the-Counter Drug Category II and III Active Ingredients’, Docket Nos. 75N-183F, 75N-183D, and 80N-0280, October 19,1998

Fournier L, Thomas, G, Garnier, R, Buisine, A, Houze, P, Pradier, F, and Dally, S 1988, ‘2,3-Dimercaptosuccinic Acid Treatment of Heavy Metal Poisoninig in Humans’, Medical Toxicology 3: 499-505 (1988)

Frackelton JP, Christensen RL, ‘Mercury Poisoning and Its Potential Impact on Hormone Regulation and Aging: Preliminary Clinical Observations Using a New Therapeutic Approach’, Journal of Advancement in Medicine 1998 Spring 11(1):9-25

Fredriksson A, Dencker L, Archer T, Danielsson BGR, ''Prenatal coexposure to metallic mercury vapour and methylmercury produce interactive behavioural changes in adult rats', Neurotoxicol Teratol 1996 19(2):129-134

Fuchs J, Packer L, Zimmer G, Lipoic Acid in Health and Disease, Marcel Dekker, Inc., 1997

Fuchs J, Schöfer H, ‘Redox Modulation of Signal Transduction and Gene Expression in HIV Infection: The Role of the Antioxidant Lipoate’, Lipoic Acid in Health and Disease, Fuchs, Packer, & Zimmer (eds), Marcel Dekker, Inc., 1997, 435-454

Fudenberg HH, ‘Dialysable Lymphocyte Extract (DLyE) in Infantile Onset Autism: A Pilot Study’, Biotherapy (1996) 9:143-147

Fukino H, Hirai M, Hsueh YM, Yamane Y, ‘Effect of zinc pretreatment on mercuric chloride-induced lipid peroxidation in the rat kidney’, Toxicol Appl Pharmacol 1984 May;73(3):395-401

Gaffney GR, Kuperman S, Tsai LY, Minchin S, ‘Morphological evidence for brainstem involvement in infantile autism’, Biological Psychiatry, September 1988, 24:578-586

Gedye A, ‘Anatomy of self-injurious, stereotypic, and aggressive movements: evidence for involuntary explanation’, Journal of Clinical Psychology, November 1992, Vol. 48, No. 6, pp. 766-778

Gilbert SG, Grant-Webster KS, ‘Neurobehavioral effects of developmental methymercury exposure’, Environmental Health Perspectives, 1995 Sept; 103 Suppl 6:135-142

Gillberg C, Coleman M, The Biology of the Autistic Syndromes - 2nd Edition, Mac Keith Press, 1992

Gillberg C, Dev Med Child Neurol 37, 23-45 (1995)

Gillberg C, Gillberg IC, 'Infantile Autism: a total population study of reduced optimality in the pre-, peri- and neonatal period', Journal of Autism and Developmental Disorders, 1983, Vol 13, No. 2, pp. 153-166

Gillberg C, Svennerholm L, ‘CSF monoamines in autistic syndromes and other pervasive dev. disorders of early childhood’, British Jour. of Psychiatry, 1987, No. 151, pp. 89-94

Gillberg C, Wing L, ‘Autism: not an extremely rare disorder’, Acta Psychiatr Scand 1999 Jun;99(6)399-406

Goldberg M, Mena I, Miller B, ‘Frontal and temporal lobe dysfunction in autism and other related disorders: ADHD and OCD’, Latin American Journal of Nuclear Medicine, July 1999, available online: http://www.alabimnjournal.cl

Golse B, Debray-Ritzen P, Durosay P, Puget K, Michelson AM, ‘Alterations in two enzymes: superoxide dismutase and glutathion peroxidase in developmental infantile psychosis’, Revue Neurologic (Paris) 1978 Nov;134(11):699-705

Gosselin RE, Smith RP, Hodge HC, Clinical Toxicology of Commercial Products, Section III, Therapeutic Index, 'Mercury', (5th edition), Baltimore, Williams & Wilkins, 1984: pp262-271.

Grandin T, ‘Brief Report: Response to National Institutes of Health Report’, Journal of Autism and Developmental Disorders, 1996, Vol. 26, No. 2, 185-187

Grandin T, ‘The Learning Style of People With Autism: An Autobiography’, Teaching Children with Autism, Kathleen Ann Quill, 33-52

Grandjean P, Budtz-Jorgensen E, White RF, Jorgensen PJ, Weihe P, Debes F, Keiding N, ‘Methylmercury exposure biomarkers as indicators of neurotoxicity in children aged 7 years’, Am J Epidemiol 1999 Aug 1; 150(3):301-305

Grandjean P, Guldager B, Larsen IB, Jergensen PJ, Holmstrup P, ‘Placebo Response in Environmental Disease’, JOEM 1997 August, Vol. 38, No. 8,707-714

Grandjean P, Weihe P, White RF, Debes F, ‘Cognitive performance of children prenatally exposed to “safe” levels of methylmercury’, Environmental Research 1998 May; 77(2): 165-172

Grandjean P, White RF, Nielsen A, Cleary D, de Oliveira Santos EC, ‘Methylmercury neurotoxicity in Amazonian children downstream from gold mining’, Environ Health Perspect 1999 Jul;107(7):587-591

Grundt IK, Stensland E, Syverson TL, ‘Changes in fatty acid composition of myelin cerebrosides after treatment of the developing rat with methylmercury chloride and diethylmercury’. J Lipid Res, 1980 Feb;21(2):162-168

Gunderson, VM, Grant KS, Burbacher TM, Fagan 3rd JF, Mottet, NK, ‘The effect of low-level prenatal methyl mercury exposure on visual recognition memory in infant crab-eating macaques’, Child Dev., 1986, 57(4):1076-1083

Gunderson, VM, Grant KS, Burbacher TM, et al, ‘Visual recognition memory deficits in methyl mercury exposed Macaca fascicularis infants’, Neurotoxicol Teratol., 1988, 10(4):373-379

Gupta S, Aggarwal S, Heads C, ‘Brief Report: Dysregulated Immune System in Children with Autism: Beneficial Effects of Intravenous Immun Globulin on Autistic Characteristics’, Journal of Autism and Developmental Disorders, 1996, Vol. 26, No. 4, 439-452

Gupta S, Aggarwal S, Rashanravan B, Lee T, ‘Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism’, J Neuroimmunol 1998 May 1;85(1):106-109

Haeney MR, Carter GF, Yeoman WB, Thompson RA, ‘Long-term parental exposure to mercury in patients with hypogammaglobulinaemia’, British Medical Journal 1979 2:12-14

Hagerman RJ, 'Possible similarities between the fragile X and Asperger syndrome', American Journal of Diseases of Children, 1987;141:601-602

Halsey NA, 'Perspective on the use of thimerosal-containing vaccines', presentation at the National Vaccine Advisory Committee Workshop on Thimerosal and Vaccines, August 11-12, 1999, available on Institute of Vaccine Safety website, www.vaccinesafety.edu

Halsey NA, ‘Limiting Infant Exposure to Thimerosal in Vaccines and Other Sources of Mercury’, JAMA, November 10, 1999, Vol. 282, No. 18

Hartman DE, 'Missed diagnoses and misdiagnoses of environmental toxicant exposure', Diagnostic Dilemmas, Part I, 1998 Sep;21(3):659-671

Hashimoto T, Tayama M, Miyazaki M, Sakurama N, Yoshimoto T, Murakawa K, Kuroda Y, ‘Reduced brainstem size in children with autism’, Brain & Development, 1992, Vol. 14, No. 2, pp. 94-97

Hashimoto T, Tayama M, Murakawa K, Yoshimoto T, Miyazaki M, Harada M, Kuroda Y, ‘Development of the brainstem and cerebellum in autistic patients’, Journal of Autism and Developmental Disorders, 1995, Vol. 25, No. 1, pp. 1-18

Haznedar MM, Buchsbaum MS, Metzger M, Solimando A, Spiegel-Cohen J, Hollander E, ‘Anterior Cingulate Gyrus Volume and Glucose Metabolism in Autistic Disorder’, Amercian Journal of Psychiatry 1997 Aug 154(8):1047-1050

Hepatitis Control Report, ‘Uproar over a little-known preservative, thimerosal, jostles U.S. hepatitis B vaccination policy’, Summer 1999, Vol. 4, No. 2

Hollander E, Kaplan A, Cartwright C, Reichman D, ‘Venlafaxine in children, adolescents, and young adults with autism spectrum disorders: an open retrospective clinical report’, J Child Neurol, 2000, Feb;15(2):132-135

Hoon AH and Riess AL, ‘The mesial-temporal lobe and autism: case report and review’, Developmental Medicine and Child Neurology 1992 34:252-265

Horvath K, Papadimitriou JC, Rabsztyn A, Drachenberg C, Tildon JT, ‘Gastrointestinal abnormalities in children with autistic disorder’, Journal of Pediatrics 1999 Nov 135(5):559-563

Hoshino Y, Watanabe M, Kumashiro H, ‘The hypothalamo-pituitary function in autistic children: the change of serum 5HT, plasma human growth hormone, prolactin level after L-5HTP loading’, Neurosciences, 1984, Vol. 10, pp. 285-291

Hoshino Y, Watanabe M, Kumashiro H, ‘The TRH and LH-RH loading test in autistic children’, Journal of Medical Science, 1985, Vol. 31, No. 1

Howlin P, 'Outcome in adult life for more able individuals with autism or Asperger syndrome', Autism 2000 Mar;4(1):63-84

Hrdina PD, Peters DA, Singhal RL 1976, ‘Effects of chronic exposure to cadmium, lead and mercury of brain biogenic amines in the rat’, Research Communications in Chemistry, Pathology and Pharacology 1976 Nov;15(3):483-493

Hu H, Abedi-Valugerdi M, Moller G, ‘Pretreatmet of lymphocytes with mercury in vitro induces a response in T cells from genetically determine low-responders and a shift of the interleukin profile’, Immunology, 1997 90:198-204

Hu H, Möller G, Abedi-Valugerdi M, ‘Major histocompatibility complex class II antigens are required for both cytokine production and proliferation induced by mercuric chloride in vitro’, J Autoimmun, Oct 1997, 10(5):441-446

Hu H, Moller G, Abedi-Valugerdi M, ‘Mechanism of mercury-induced autoimmunity: both T helper 1- and T helper 2-type responses are involved’, Immunology, March 1999, 96(3):348-357

Hua MS, Huang CC, Yang YJ, 'Chronic elemental mercury intoxication: neuropsychological follow up case study', Brain Inj 1996 May;10(5):377-84

Hultman P, Hansson-Georgiadis H, ‘Methyl mercury-induced autoimmunity in mice’, Toxicol Appl Pharmacol, Feb 1, 1999, 154(3):203-211

Hultman P, Nielsen JB, ‘The effect of toxicokinetics on murine mercury-induced automimunity’, Environ Res, May 1998, 77(2):141-148

Hultman P, Turley SJ, Eneström S, Lindh U, Pollard KM, ‘Murine genotype influences the specificity, magnitude and persistence of murine mercury-induced autoimmunity’, J Autoimmun, April 1996, 9(2): 139-149

Hussain S, Atkinson A, Thompson SJ, Khan AT, ‘Accumulation of mercury and its effect on antioxidant enzymes in brain, liver, and kidneys of mice’, J Environ Sci Health B 1999 Jul;34(4):645-660

Ikeda M, Komachi H, Sato I, Himi T, Yuasa T, Murota S, ‘Induction of neuronal nitric oxide synthase by methylmercury in the cerebellum’, Journal of Neuroscience Research 1999 Feb 1;55(3):352-356.

Ikeda M, Komachi H, Sato I, Himi T, Yuasa T, Murota S, ‘Induction of neuronal nitric oxide synthase by methylmercury in the cerebellum’, J Neurosci Res 1999 Feb 1;55(3):352-356

Ilback NG, ‘Effects of methyl mercury exposure on spleen and blood natural-killer (NK) cell-activity in the mouse’, Toxicology, 1991, 67(1):117-124

Islam MS, Berggren PO, Larsson O, ‘Sulfhydryl oxidation induces rapid and reversible closure of the ATP-regulated K+ channel in the pancreatic beta cell’, FEBS Lett 1993 Mar 15;319(1-2):128-132

Jaffe JS, et al, ‘Functional abnormalities of CD8+ t cells define a unique subset of patients with common variable immunodeficiency’, Blood, 1993, 82.1.192-2001

Jaselskis C, Cook E, Fletcher K, and Bennett L, ‘Clonidine treatment of hyperactive and impulsive children with autistic disorder’, Journal of Clinical Psychopharmacology 1992

Johansson U, Hansson-Georgiadis H, Hultman P, ‘The genotype determines the B cell response in mercury-treated mice’, Int Arch Allergy Immunol, Aug 1998, 116(4):295-305

Joselow MM, Louria DB, Browder AA, ‘Mercurialism: Environmental and Occupational Aspects’, Annals of Internal Medicine 1972 76:119-130

Joseph SK, Ryan SV, Pierson S, Renard-Rooney D, Thomas AP, ‘The effect of mersalyl on inositol trisphosphate receptor binding and ion channel function’, J Biol Chem 1995 Feb 24;270(8):3588-3593

Journal of Autism and Developmental Disorders, 1995, Vol. 25, No. 2

Kabuto M, ‘Chronic effects of methylmercury on the urinary excretion of catecholamines and their responses to hypoglycemic stress’, Arch Toxical 1991;65(2):164-167

Kanner L, ‘Autistic Disturbances of Affective Contact’, The Nervous Child 1942-1943, Vol. 2, No. 3, 217-250

Karhapaa l, Titievsky A, Kaila K, Tornquist K, ‘Redox modulation of calcium entry and release of intracellular calcium by thimerosal in GH4C1 pituitary cells’, Cell Calcium 1996 Dec;20(6):447-457

Kark RA, Poskanzer DC, Bullock JD, Boylen G. ‘Mercury poisoning and its treatment with N-acetyl-D, L-penicillamine’, New England Journal of Medicine 1971;285:10-16

Kates WR, Mostofsky SH, Zimmerman AW, Mazzocco MM, Landa R, Warsofsky IS, Kaufmann WE, Reiss AL, ‘Neuroanatomical and neurocognitive differences in a pair of monozygous twins discordant for strictly defined autism’, Ann Neurol 1998 Jun; 43(6):782-791

Kinoshita Y, Ohnishi A, Kohshi K, Yokota A, ‘Apparent diffusion coefficient on rat brains and nerves intoxicated with methylmercury’, Environ Res 1999 May;80(4):348-354.

Klin A, Sparrow SS, de Bildt A, Cicchetti DV, Cohen DJ, Volkmar FR, 'A Normed Study of Face Recognition in Autism and Related Disorders', Journal of Autism and Developmental Disorders December 1999 29:6 499-508

Koegel LK, Koegel RL, Smith A, ‘Variables Related to Differences in Standardized Test Outcomes For Children with Autism’, Journal of Autism and Developmental Disorders, 1997, Vol. 27, No. 3, 233-243

Koos BJ and Longo LD, ‘Mercury toxicity in the pregnant woman, fetus, and newborn infant’, American Journal of Obstetrics and Gynecology 1976 Oct 126(3):390-406

Kugler B, 'The differentiation between autism and Asperger syndrome', Autism, 1998 Mar;2(1):11-32

Kurita H, ‘Infantile autism with speech loss before the age of thirty months’, Journal of the American Academy of Child Psychiatry, 1985, Vol. 24, Issue 2, pp. 191-196

LaCamera RG, LaCamera AC, 'Routine Health Care', Handbook of Autism and Pervasive Developmental Disorders, Cohen D, Donnellan AM, Paul R, eds, 1987 by John Wiley & Sons, Inc., p584-595

Larkfors L, Oskarsson A, Sundberg J, Ebendal T, ‘Methylmercury induced alterrations in the nerve growth factor level in the developing brain’, Brain Res Dev Brain Res 1991 Oct 21; 62(2) 287-291

Leboyer M, Philippe A, Bouvard M, Guilloud-Bataille M, Bondoux D, Tabuteau F, Feingold J, Mouren-Simeoni MC, Launay JM, 'Whole blood serotonin and plasma beta-endorphin in autistic probands and their first-degree relatives', Biol Psychiatry 1999 Jan 15;45(2):158-63

Lewine 'Magnetoenchalography in Children with an Autistic Epileptiform Regression', J Pediatrics, 1999 405-418

Lewis MH, ‘Brief Report: Psychopharmacology of Autism Spectrum Disorders’, Journal of Autism and Developmental Disorders, 1996, Vol. 26, No. 2, 231-235

Li S, Thompson SA, Woods JS, ‘Localization of gamma-glutamylcysteine synthetase mRNA expression in mouse brain following methylmercury treatment using reverse transcription in situ PCR amplification’, Toxicol Appl Pharmacol, Sept 1996, 140(1):180-187

Lombard J, ‘Autism: a mitochondrial disorder?’, Medical Hypotheses 1998 Jun;50(6):497-500

Lorscheider FL, Vimy MJ, Summers AO, ‘Mercury exposure from “silver” tooth fillings: emerging evidence questions a traditional dental paradigm’, The FASEB Journal, April 1995, Vol. 9, 504-508

Lowell JA, Burgess S, Shenoy S, Curci JA, Peters M, Howard TK, ‘Mercury Poisoning Associated with High-Dose Hepatitis-B Immune Globulin Administration After Liver Transplantation for Chronic Hepatitis B’, Liver Transplantation and Surgery, Nov 1996, Vol. 2, No. 6, 475-478

Magos L, Brown AW, Sparrow S, Bailey E, Snowden RT, Skipp WR, ‘The comparative toxicology of ethyl- and methylmercury’, Archives of Toxicology, 1985 Sep;57(4):260-267

Malhotra S, Gupta N, 'Childhood Disintegrative Disorder', Journal of Autism and Developmental Disorders Dec 1999 29;6 491-498

Markovich D, Knight D, 'Renal Na-Si Cotransporter NaSi-1 is inhibited by heavy metals', American Journal of Renal Physiology, February 1998, Vol. 274, No. 2, pp283-289

Marty MS, Atchison WD, ‘Elevations of intracellular Ca2+ as a probable contributor to decreased viability in cerebellar granule cells following acute exposre to methyl mercury’, Toxicol Appl Pharmacol 1998 May’ 150(1):98-105

Matheson DS, Clarkson TW, Gelfand EW, ‘Mercury toxicity (acrodynia) induced by long-term injection of gammaglobulin’, Journal of Pediatrics 1980;97(1):153-155.

Mathiesen T, Ellingsen DG, Kjuus H, ‘Neuropsychological effects associated with esposure to mercury vapor among former chloralkali workers’, Scand J Work Environ Health, 1999, Aug:25(4):342-350

Mattsson JR, Miller E, Alligood JP, Koering JE, Levin SG, ‘Early effects of methylmercury on the visual evoked response of the dog’, Neurotoxicology 1981 Nov;2(3):499-514

McClelland RJ, Eyre D, Watson D, Calvert J, ‘A neurophysiological study of autistic children’, Electroencephalography and Clinical Neurophysiology, Sept. 1985, Vol. 61, p. 16

McClelland RJ, Eyre DG, Watson D, Calvert GJ, Sherrard E, British Journal of Psychiatry, 1992, 160: 659-663

McDougle C, Psycholopharmacology, Handbook of Autism and Pervasive Developmental Delay, 2nd ed. New York: John Wiley and Sons, 1997;707:729

McDougle CJ, Brodkin ES, Yeung PP, Naylor ST, Cohen DJ, Price LH, ‘Risperidone in adults with autism or pervasive developmental disorder’, Journal of Child and Adolescent Psychopharmacology, 1995, Vol. 5, No. 4, pp. 273-282

McDougle CJ, Homes JP, Bronson MR, Anderson GM, Volkmar FR, Price LH, Cohen DJ, ‘Risperidone treatment of children and adolescents with pervasive developmental disorders: A prospective open-label study’, Journal of the American Academy of Child and Adolescent Psychiatry, 36, 685-693

McKay SJ, Reynolds JN, Racz WJ, ‘Effects of mercury compounds on the spontaneous and potassium-evoked release of [3H]dopamine from mouse striatal slices’, Canadian Journal of Physiology and Pharmacology 1986 Dec 64(12):1507-1514

McKeown-Eyssen GE, Ruedy J, Neims A, ‘Methyl mercury exposure in northern Quebec: II. Neurologic findings in children’, Am. J. Epidemiol., 1983, 118:470-479

Merck & Co., Inc., ‘Merck Launches Preservative-Free Hepatitis-B Vaccine’, press release, Sept 9, 1999

Messahel S, Pheasant AE, Pall H, Ahmed-Choudhury J, Sungum-Paliwal RS, Vostanis P, ‘Urinary levels of neopterin and biopterin in autism’, Neurosci Lett 1998 Jan 23;241(1):17-20

Minnema DJ, Cooper GP, Greenland RD, ‘Effects of methylmercury on neurotransmitter release from rat brain synaptosomes’, Toxicology and Applied Pharmacology 1989 Jul 99(3):510-521

Minshew NJ, ‘Brief Report: Brain Mechanisms in Autism: Functional and Structural Abnormalities’, Journal of Autism and Developmental Disorders, 1996, Vol. 26, No. 2, 205-209

Moreno H, Borjas L, Arrieta A, Saez L, Prassas A, Estevez J, Bonilla E, ‘Clinical heterogeneity of the autistic syndrome: a study of 60 families’ (Spanish), Invest Clin 1992;33(1):13-31

Moreno-Fuenmayor H, Borjas L, Arrieta A, Valera V, Socorro-Candanoza L, ‘Plasma excitory amino acids in autism’, Invest Clin 1996 Jun;37(2):113-128

Muris P, Steerneman P, Merckelbach H, Holdrinet I, Meesters C, ‘Comorbid anxiety symptoms in children with pervasive developmental disorders’, Journal of Anxiety Disorders, 1998, Vol. 12, No. 4, pp. 387-393

Musiek FE, Hanlon DP, ‘Neuroaudiological effects in a case of fatal dimethylmercury poisoning’, Ear Hear 1999 Jun;20(3):271-275

Myers GJ, Davidson PW, ‘Prenatal methylmercury exposure and children: neurologic, developmental, and behavior research’, Environmental Health Perspectives, 1998 Jun;106 Suppl 3:841-847.

Nass R, Gross A, Devinsky O, 'Autism and autistic epileptiform regression with occipital spikes', Dev Med Child Neurol 1998 Jul;40(7):453-8

‘Neville’s (a Pinkie) Recollection of Pink Disease’, Pink Disease Support Group, www.users.bigpond.com/difarnsworth

Nielsen JB and Hultman P, ‘Experimental studies on genetically determined susceptibility to mercury-induced autoimmune response’, Renal Failure 1999 21(3&4):343-348

Nishio H, Nezasa K, Hirano J, Nakata Y, ‘Effects of thimerosal, an organic sulfhydryl modifying agent, on serotonin transport activity into rabbit blood platelets’, Neurochemistry International 1996 29(4):391-396

Nordin V, Gillberg C, ‘Autism Spectrum disorders in children with physical or mental disability or both. I: Clinical and epidemiological aspects’, Dev Med Child Neurol 1996 Apr; 38(4):297-313

Nowell MA, Hackney DB, Muraki AS, Coleman M, 'Varied MR appearance of autism: fifty-three pediatric patients having the full autistic syndrome', Magn Reson Imaging 1990;8(6):811-6

O’Carroll RE, Masterton G. Dougnall N. Ebmeier KP, 1995, ‘The neuropsychiatric sequelae of mercury poisoning: The Mad Hatter’s disease revisited’, British Journal of Psychiatry 167(1):95-98 (1995)

O’Kusky JR, Boyes BE, McGeer EG, ‘Methylmercury-induced movement and postural disorders in developing rat: regional analysis of brain catecholamines and indoleamines’, Brain Research 1988 Jan 26;439(1-2):138-146

O’Neill JL, Through the Eyes of Aliens, Jessica Kingsley Publishers Ltd., 1999

O’Neill M, Jones RSP, ‘Sensory-Perceptual Abnormalities in Autism: A Case For More Research?’, Journal of Autism and Developmental Disorders, 1997, Vol. 27, No. 3, 283-293

O’Reilly BA and Waring, R, ‘Enzyme and sulfur oxidation deficiencies in autistic children with known food/chemical intolerances’, Journal of Orthomolecular Medicine 1993 4:198-200

Ono B, Sakamoto E, ‘Saccharomyces cerevisiae strains sensitive to inorganic mercury. I. Effect of tyrosene’, Curr Genet 1985;10(3):179-185

Ono B, Sakamoto E, Yamaguchi K, ‘Saccharomyces cerevisiae strains sensitive to inorganic mercury. III. Tyrosine uptake’, Curr Genet 1987;11(5):399-406

O'Reilly B, Waring R, 'Enzyme and Sulphur Oxidation Deficienceies in Autistic Children with Known Food/Chemical Intolerences', pp. 249-252

Ornitz EM, ‘Neurophysiologic Studies of Infantile Autism’, Handbook of Autism and Pervasive Developmental Disorders, John Wiley & Sons, Inc., 1987, 148-165

Otsuka H, 'Brain Metabolites in the Hippocampus-amygdala Region and Cerebellum in Autism: an 1H-MR Spectroscopy Study', Neuroradiology 1999 Jul

Page T, Coleman M, ‘Purine metabolism abnormalities in a hyperuricosuric subclass of autism’, Biochim Biophys Acta, 2000 Mar 17;1500(3):291-296

Page T, Yu A, Fontanesi J, Nyhan WL, ‘Developmental disorder associated with increased cellular nucleotidase activity’, Proc. Natl. Acad. Sci. USA, Vol. 94, October 1997, 11601-11606

Paul R, ‘Natural History’, Handbook of Autism and Pervasive Developmental Disorders, John Wiley & Sons, Inc., 1987, 121-132

Pedersen MB, Hansen JC, Mulvad G, Pedersen HS, Gregersen M, Danscher G, ‘Mercury accumulations in brains from populations exposed to high and low dietary levels of methyl mercury. Concentration, chemical form and distribution of mercury in brain samples from autopsies’, Int J Circumpolar Health 1999 Apr;58(2): 96-107

Pediatrics 1999; 104:570-574, 'Thimerosal in vaccines: an interim report to clinicians', Committee on Infectious Disease and Committee on Environmental Health

Pendergrass JC, Haley BE, Vimy MJ, Winfield SA, Lorscheider FL, ‘Mercury vapor inhalation inhibits binding of GTP to tubulin in rat brain: similarity to a molecular lesion in Alzheimer diseased brain’, Neurotoxicology 1997;18(2):315-324

Perry E, Lee M, Court J, Perry R, 'Cholinergic Activities in Autism: Nicotinic and Muscarinic Receptor Abnormalities in the Cerebral Cortex' , presentation to Cure Autism Now, 2000

Pfab R, Muckter H, Roider G, Zilker T, ‘Clinical course of severe poisoning with thiomersal’, Clinical Toxicology 1996;34(4):453-460

Pierce PE, Jon F. Thompson, MPH William H. Likosky, MD; Laurance N. Nickey, MD; William F. Barhtel; and Alan R. Hinman, MD, MPH, ‘Alkyl Mercury Poisoning in Humans’, JAMA 1972 Vol 220, No11 1439-1442

Piikivi L, Hanninen H, Martelin T, et al, ‘Psychological performance and long-term exposure to mercury vapors’, Scand. J. Work Environ. Health, 1984, 10:35-41

Piikivi L, Tolonen U, ‘EEG findings in chlor-alkali workers subject to low long term exposure to mercury vapor’, Br. J. Ind. Med., 1989, 46(6):370-375

Pink Disease Support Group, www.users.bigpond.com/difarnsworth

Pirker C, Möslinger T, Wantke F, Götz, Jarisch R, ‘Ethylmercuric chloride: the responsible agent in thimerosal hypersensitivity’, Contact Dermatitis 1993:29:152-154

Piven J, Berthier M, Starkstein S, Nehme E, Pearlson G, Folstein S, ‘Magnetic resonance imaging evidence for a defect of cerebral cortical development in autism’, American Journal of Psychiatry, June 1990, 147:6, pp. 734-739

Piven J, Palmer P, ‘Psychiatric disorder and the broad autism phenotype: evidence from a family study of multiple-incidence autism families’, American Journal of Psychiatry, April 1999, Vol. 156, No. 4, pp. 557-563

Pless R, 'Summary of the Workshop on Thimerosal in Vaccines', Report from the National Immunization Program, CDC, 1999

Plioplys A, 'Autism: Biomedical Perspectives', Presentation for the Autism Society of America meeting, July 1989

Plioplys AV, Greaves A, Kazemi K, Silverman E, ‘Immunoglobin reactivity in autism and Rett’s syndrome’, Developmental Brain Dysfunction, 1994, 7:12-16

Plioplys AV, Greaves A, Kazemi K, Silverman E, ‘Lymphocyte function in autism and Rett Syndrome’, Neuropsychobiology 1994;29(1) :12-6

Plioplys AV, Hemmens SE, Regan CM, 'Expression of a neural cell adhesion molecule serum fragment is depressed in autism', J Neuropsychiatry Clin Neurosci, 1990 Fall;2(4):413-7

Plotkin S, Orenstein W, Vaccines 1999

Prechtl HFR, 'Neurological Findings in Newborn Infants after Pre- and Paranatal complications', Jonxis et al editors:Aspects of Prematurity and Dysmaturity: a Nutrica symposium, Leiden:Stenfert Kroesse, 1968

Prizant BM, ‘Brief Report: Communication, Language, Social, and Emotional Development’, Journal of Autism and Developmental Disorders, 1996, Vol. 26, No. 2, 173-178

Purine Research Society, 'What We Learn About Metabolic Disease Will Benefit Each and Every One of Us', Purine Research Society Website

Puschel G, Mentlein R, Heymann E, 'Isolation and characterization of dipeptidyl peptidase IV from human placenta', Eur J Biochem 1982 Aug;126(2):359-65

Rajanna B and Hobson M, ‘Influence of mercury on uptake of [3H]dopamine and [3H]norepinephrine by rat brain synaptosomes’, Toxicology Letters 1985 Sep 27(1-3):7-14

Rajanna B, Hobson M, Harris l, Ware L, Chetty CS, ‘Effects of cadmium and mercury on Na(+)-K+, ATPase and uptake of 3H-dopamine in rat brain synaptosomes’, Arch Int Physiol Biochim 1990 Oct;98(5):291-296

Rice D, 'Lack of Effect of Methylmercury Exposure from Birth to Adulthood on Information Processing Speed in the Monkey', September 1997,

Rice DC, ‘Sensory and cognitive effects of developmental methylmercury exposure in monkeys, and a comparison to effects in rodents’, NeuroToxicol., 1996, 17:139-154

Rice DC, Gilbert SG, ‘Early chronic low-level methylmercury poisoning in monkeys impairs spatial vision’ Science 1982 May 14;216(4547):759-761

Richdale AL, 'Sleep problems in autism: prevalence, cause, and intervention', Developmental Medicine and Child Neurology, 1999 Jan 41(1):60-6

Rimland B, ‘Recovery from autism is possible’, cited in Autism Research Review International, 1994, Vol. 8, No. 2, p. 3

Rimland B, Baker SM, ‘Brief Report: Alternative Approaches to the Development of Effective Treatments for Autism’, Journal of Autism and Developmental Disorders, 1996, Vol. 26, No. 2, 237-241

Ritvo ER, Freeman BJ, Scheibel AB, Duong T, Robinson H, Guthrie D, Ritvo A, 'Lower Purkinje cell counts in the cerebella of four autistic subjects: intitial findings of the UCLA-NSAC Autopsy Research Report', American Journal of Psychiatry, 1986;143:862-866

Ritvo ER, Freeman BJ, Creel D, Crandall AS, Pingree C, Barr R, Realmuto G, ‘Retinal Pathology in Autistic Children – A Possible Biological Marker for Subtype?’ (letter), Journal of the American Academy of Child Psychiatry, January 1986, 25:137

Rodier PM, Ingram JL, Tisdale B, Croog VJ, ‘Linking etiologies in humans and animal models: studies of autism’, Reproductive Toxicology, 1997, Vol. 11, Nos. 2/3, pp. 417-422

Rodier, P.M., M. Aschner and P. R. Sager. 1984. Mitotic arrest in the developing CNS after prenatal exposure to methyl mercury. Neurobehav. Toxical. Teratol. 6:379-385.

Rogers SJ, ‘Brief Report: Early Intervention in Autism’, Journal of Autism and Developmental Disorders, 1996, Vol. 26, No. 2, 243-246

Rogers T, Kalaydjieva, Hallmayer et al, 'Exclusion of Linkage to the HLA Region in Ninety Multiplex Sibships with Autism', Journal of Autism and Developmental Disorders, 1999 Jun;29(3):195-202

Rohyans J, Walson PD, Wood GA, MacDonald WA, ‘Mercury toxicity following merthiolate ear irrigations’, The Journal of Pediatrics, 1984 Feb:311-313

Romani L, ‘Immunity to Candida albicans: Th1, TH2 cells and beyond’, Curr Opin Microbiol 1999 Aug;2(4): 363-367

Rosenhall U, Johansson E, Gillberg C, ‘Oculomotor findings in autistic children’, Journal of Laryngology and Otology, May 1988, Vol. 102, pp. 435-439

Rosenhall U, Nordin V, Sandstrom M, Ahlsen G, Gillberg C, 'Autism and Hearing Loss', Journal of Autism and Developmental Disorders, Oct 1999 29(5) 349-358

Ross W. Donald, Gechman A, Sholiton M, Paul H, 'Alertness to Neuropsychiatric Manifestations', Comprehensive Psychiatry, Vol. 18, No. 6, pp. 595-598

Rossi AD, Ahlbom E, Ogren So, Nicotera P, Ceccatelli S, ‘Prenatal exposure to methylmercury alters locomotor activity of male but not female rats’, Exp Brain Res 1997 Dec;117(3):428-436

Roux S, Adrien J-L, Bruneau N, Malvy J, Barthelemy C, 'Behavior Profiles within a population of 145 children with autism using the Behaviour Summarized Evaluation scale: influence of developmental age', Autism, 1998 (Dec) 2(4) 235-266

Rumsey J, ‘Conceptual problem-solving in highly verbal, nonretarded autistic men’, Journal of Autism and Dev. Disorders, 1985, Vol. 15, No. 1, pp. 23-36

Rumsey JM, Hamburger SD, ‘Neuropsychological findings in high-functioning men with infantile autism, residual state’, Journal of Clinical and Experimental Neuropsychology, 1988, Vol. 10, No. 2, pp. 201-221

Russell J, Jarrold C, Hood B, ‘Two Intact Executive Capacities in Children with Autism: Implications for the Core Executive Dysfunctions in the Disorder’, Journal of Autism and Developmental Disorders, 1999, Vol. 29, No. 2, 103-112

Rutter M, 'Autism research: prospects and priorities', Journal of Autism and Developmental Disorders 1996 Apr;26(2):257-75

Rutter M, ‘The development of infantile autism’, Psychological Medicine 1974 4:147-163

Ryu YH, Lee JD, Yoon PH, Kim DI, Lee HB, Shin YJ, ‘Perfusion impairments in infantile autism on technetium-99m ethyl cysteinate dimer brain single-photon emission tomography: comparison with findings on magnetic resonance imaging’, Eur J Nucl Med 1999 Mar;26(3):253-259

Sager. P.R., Aschner, M., and Rodier, P.M. 'Persistent differential alteration in developing cerebellar cortex of male and female mice after methylmercury exposure', Dev. Brain Res. 12: 1-11 (1984)

Sakamoto E, Urata H, Ono B, ‘Saccharomyces cerevisiae strains sensitive to inorganic mercury. II. Effect of glucose’, Curr Genet 1985;10(3):187-195

Sarafian TA, Bredesen DE, Verity MA, ‘Cellular resistance to methylmercury’, Neurotoxicology, 1996 Spring Abstract, 17(1):27-36

Sayers LG, Brown GR, Michell RH, Michelangeli F, ‘The effects of thimerosal on calcium uptake and inositol 1,4,5-triosphate-induced calcium release in cerebellar microsomes’, Biochem J 1993 Feb 1;289 (Pt 3):883-887

Scheyer RD, 'Involvement of Glutamate in Human Epileptic Activities', Prog Brain Res, 1998, Vol. 116, pp. 359-369

Schuler AL, ‘Thinking in Autism: Differences in Learning and Development’, Teaching Children with Autism, Kathleen Ann Quill, ed., 1995, 11-32

Sears LL, 'An MRI Study of the Basal Ganglia in Autism', Prog Neuropsychopharmacol Biol Psychiatry, 1999 May

Shafer TJ, Atchison WD, ‘Transmitter, ion channel and receptor properties of pheochromocytoma (PC12) cells: a model for neurotoxicological studies’, Neurotoxicology 1991 Fall;12(3):473-492

Shattock P, Savery D, Autism as a Metabolic Disorder, Autism Research Unit, University of Sunderland, Sunderland, UK, 1997

Shenker BJ, Datar S, Mansfield K, Shapiro IM, ‘Induction of apoptosis in human T-cells by organomercuric compounds: a flow dytometric analysis’, Toxicol Appl Pharmacol, April 1997, 143(2): 397-406

Shenker BJ, Guo TL, Shapiro IM, ‘Low-level methylmercury exposure causes human T-cells to undergo apoptosis: evidence of mitochondrial dysfunction’, Environmental Research, 1998 May; Section A 77(2):149-159

Shenker, B.J., Berthold, P., DeBolt, K., Rooney, C., Vitale, L.A., and Shapiro, I.M. (1992). 'Immunotoxic effects of mercuric compounds on human lymphocytes and monocytes. II. Alterations in cell viability', Immunopharm. Immunotox. 14, 555-577.

Shenker, B.J., Berthold, P., Decker, S., Mayro, J.S., Rooney, C., Vitale, L.A., and Shapiro, I.M. (1993). 'Immunotoxic effects of mercuric compounds on human lymphocytes and monocytes. III. Alterations in B-cell function and viability', Immunopharm. Immunotox. 15, 87-112.

Siegel BV, Nuechterlein KH, Abel L, Wu JC, Buchsbaum MS, ‘Glucose metabolic correlates of continuous performance test performance in adults with a history of infantile autism, schizophrenics, and controls’, Schizophrenia Research 1995 Sep 17(1):85-94

Sigman M, Ungerer JA, Mundy P, Sherman T, ‘Cognition in Autistic Children’, Handbook of Autism and Pervasive Developmental Disorders, John Wiley & Sons, Inc., 1987, 103-130

Singh VK, 'Plasma increase of Interleuken-12 and Interferon-gamma. Pathological significance in autism', J Neuroimmunology, 1996 May;66(1-2):143-5

Singh VK, Warren RP, Odell D, 'Immune response to brain myelin in autistic children', July 1992

Singh V, Warren R, Odell J, Warren W, Cole P, 'Antibodies to myelin basic protein in children with autistic behavior', Brain, Behavior and Immunity
1   ...   9   10   11   12   13   14   15   16   17

Похожие:

Sallie Bernard* Albert Enayati, B. S., Ch. E., M. S. M. E. Heidi Roger iconDr. Heidi Keller List of Publications

Sallie Bernard* Albert Enayati, B. S., Ch. E., M. S. M. E. Heidi Roger iconMurphy, James Bernard, 1958

Sallie Bernard* Albert Enayati, B. S., Ch. E., M. S. M. E. Heidi Roger iconDr. Frits Bernard, Editor(1920-2006)

Sallie Bernard* Albert Enayati, B. S., Ch. E., M. S. M. E. Heidi Roger iconLe princpe / sous la direction de Bernard Mabille

Sallie Bernard* Albert Enayati, B. S., Ch. E., M. S. M. E. Heidi Roger iconPublications by Albert E. Steenge

Sallie Bernard* Albert Enayati, B. S., Ch. E., M. S. M. E. Heidi Roger icon) stars as a very animated Heidi who is unfairly separated from her loving grandfather (Burl Ives), and forced to live with a gaggle of despicable relatives in

Sallie Bernard* Albert Enayati, B. S., Ch. E., M. S. M. E. Heidi Roger iconRoger B. Hammer

Sallie Bernard* Albert Enayati, B. S., Ch. E., M. S. M. E. Heidi Roger iconTake a look at Roger Ebert's 2002

Sallie Bernard* Albert Enayati, B. S., Ch. E., M. S. M. E. Heidi Roger iconA review of Roger Congleton

Sallie Bernard* Albert Enayati, B. S., Ch. E., M. S. M. E. Heidi Roger iconEncyclopedia of freemasonry and its kindred sciences by albert c. Mackey m. D


Разместите кнопку на своём сайте:
lib.convdocs.org


База данных защищена авторским правом ©lib.convdocs.org 2012
обратиться к администрации
lib.convdocs.org
Главная страница